Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06153940 · ClinicalTrials.gov registry record
Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up
A clinical trial of Hip Disease, sponsored by Signature Orthopaedics.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06153940 is a study of Hip Disease that is actively recruiting participants, run by Signature Orthopaedics. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06153940, a study of Hip Disease, is actively recruiting participants, sponsored by Signature Orthopaedics.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the Study is to monitor the performance of the Signature Orthopaedics Everglade Stem, World Acetabular Cup and World Liner as a part of post-market vigilance and continuous improvement efforts.
Conditions Studied
Interventions
- DEVICE Treatment
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-22 |
| Est. Completion | 2028-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06153940
The ClinicalTrials.gov registry entry for NCT06153940 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Signature Orthopaedics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hip Disease appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.
NCT06153940 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06153940 about?
NCT06153940 is a clinical study titled "Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up". The aim of the Study is to monitor the performance of the Signature Orthopaedics Everglade Stem, World Acetabular Cup and World Liner as a part of post-market vigilance and continuous improvement efforts.
What is the current status of trial NCT06153940?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-11-22. Estimated completion is 2028-03-01.
What conditions does trial NCT06153940 study?
This clinical trial studies the following conditions: Hip Disease.
What interventions are being tested in trial NCT06153940?
The interventions under investigation include: Treatment (DEVICE).
Who is sponsoring clinical trial NCT06153940?
This trial is sponsored by Signature Orthopaedics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06153940 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.